The interaction of cisplatin and analogues with DNA in reconstituted chromatin

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1579, Issue 2-3, 2002, Pages 142-152

  Galea, Anne M ^a   Murray, Vincent ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

5S rRNA gene; Cisplatin analogue; Nucleosome core; Nucleosome linker; Reconstituted nucleosome

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CELL DNA; CISPLATIN; CISPLATIN DERIVATIVE; DEOXYRIBONUCLEASE I; DICHLORO[N [3 [(2 AMINOETHYL)AMINO]PROPYL]ACRIDINE 4 CARBOXAMIDE]PLATINUM; PLATINUM DICHLORODICYCLOHEXYLAMINE; RNA 5S; TAQ POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DENSITOMETRY; DNA ADDUCT; DNA DAMAGE; DNA FOOTPRINTING; DNA PURIFICATION; DNA SEQUENCE; DRUG DNA BINDING; DRUG DNA INTERACTION; DRUG MECHANISM; GENE TARGETING; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RNA GENE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHROMATIN; CISPLATIN; DNA; DNA DAMAGE; DNA FOOTPRINTING; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NUCLEOSOMES; RNA, RIBOSOMAL, 5S; XENOPUS;

XENOPUS BOREALIS;

EID: 0037069761     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(02)00535-3     Document Type: Article

References (42)

1. Loeher P.J., Einhorn L.H. Drugs five years later, cisplatin. Ann. Intern. Med. 100:1984;704-713.
2. Zamble D.B., Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biol. Sci. 20:1995;435-439.
3. Harrap K.R. Initiatives with Platinum- and Quinazoline-based antitumor molecules. Cancer Res. 55:1995;2761-2768.
4. Rosenberg B. Fundamental studies with cisplatin. Cancer. 55:1985;2303-2316.
5. Bruhn S.L., Toney J.H., Lippard S.J. Biological processing of DNA modified by platinum compounds. Prog. Inorg. Chem.: Bioinorg. Chem. 38:1991;478-517.
6. Roberts J.J., Thomson A.J. The mechanism of action of anti-tumor platinum compounds. Prog. Nucleic Acid Res. Mol. Biol. 22:1979;71-133.
7. Fichtinger Schepman A.M., van der Veer J.L., den Hartog J.H., Lohman P.H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 24:1985;707-713.
8. Dabrowiak J.C., Bradner W.T. Platinum antitumour agents. Prog. Med. Chem. 24:1987;129-158.
9. Ponti M., Forrow S.M., Souhami R.L., D'Incalci M., Hartley J.A. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res. 19:1991;2929-2933.
10. Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A., McFadyen W.D. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J. Biol. Chem. 267:1992;18805-18809.
11. Comess K.M., Burstyn J.N., Essigmann J.M., Lippard S.J. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry. 31:1992;3975-3990.
12. Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A., McFadyen W.D. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Biochemistry. 31:1992;11812-11817.
13. Grimaldi K.A., McAdam S.R., Souhami R.L., Hartley J.A. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells. Nucleic Acids Res. 22:1994;2311-2317.
14. Murray V., Whittaker J., McFadyen W.D. DNA sequence selectivity of cisplatin analogues in intact human cells. Chem.-Biol. Interact. 110:1998;27-37.
15. Davies N.P., Hardman L.C., Murray V. The effect of chromatin proteins on cisplatin damage in intact human cells. Nucleic Acids Res. 28:2000;2954-2958.
16. Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on anti-tumour agents. (Review) Prog. Nucleic Acid Res. Mol. Biol. 63:2000;367-415.
17. Adams C.C., Workman J.L. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol. Cell. Biol. 15:1995;1405-1421.
18. Lorch Y., Zhang M., Kornberg R.D. Histone octamer transfer by a chromatin re-modeling complex. Cell. 96:1999;389-392.
19. Talasz H., Sapojnikova N., Helliger W., Lindner H., Puschendorf B. In vitro binding of H1 histone subtypes to nucleosomal organised mouse mammary tumour virus long terminal repeat promoter. J. Biol. Chem. 273:1998;32236-32243.
20. Moyer R., Marien K., van Holde K., Bailey G. Site-specific aflatoxin B1 adduction of sequence-positioned nucleosome core particles. J. Biol. Chem. 264:1989;12226-12231.
21. Smith B.L., MacLeod M.C. Covalent binding of the carcinogen benzo[a]pyrene diol epoxide to Xenopus laevis 5 S DNA reconstituted into nucleosomes. J. Biol. Chem. 268:1993;20620-20629.
22. Smith B.L., Bauer G.B., Povirk L.F. DNA damage induced by bleomycin, neocarzinostatin, and melphalan in a precisely positioned nucleosome. Asymmetry in protection at the periphery of nucleosome-bound DNA. J. Biol. Chem. 269:1994;30587-30594.
23. Pruss D., Wolffe A.P. Histone-DNA contacts in a nucleosome core containing a Xenopus 5S rRNA gene. Biochemistry. 32:1993;6810-6814.
24. Noll M. Internal structure of the chromatin subunit. Nucleic Acids Res. 1:1974;1573-1578.
25. van Holde K.E. Chromatin. 1989;Springer-Verlag, New York.
26. 2]. Indian J. Chem. 8:1970;193-194.
27. Harrison R.C., McAuliffe C.A., Zaki A.M. An efficient route for the preparation of highly water soluble platinum(II) antitumour agents. Inorg. Chim. Acta. 46:1980;L15-L16.
28. Braddock P.D., Connors T.A., Jones M., Khokhar A.R., Melzack D.H., Tobe M.L. Structure and activity relationships of platinum complexes with anti-tumour activity. Chem.-Biol. Interact. 11:1975;145-161.
29. Tremethick D.J., Frommer M. Partial purification, from Xenopus laevis oocytes, of an ATP-dependent activity required for nucleosome spacing in vitro. J. Biol. Chem. 267:1992;15041-15048.
30. Drew H.R., Calladine C.R. Sequence-specific positioning of core histones on an 860 base-pair DNA. Experiment and theory. J. Mol. Biol. 195:1987;143-173.
31. Rhodes D. Structural analysis of a triple complex between the histone octamer, a Xenopus gene for 5S RNA and transcription factor IIIA. EMBO J. 4:1985;3473-3482.
32. Hayes J.J., Tullius T.D., Wolffe A.P. The structure of DNA in a nucleosome. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7405-7409.
33. Murray V., Whittaker J.K., Temple M.D., McFadyen W.D. Interaction of eleven cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues. Biochem. Biophys. Acta. 1354:1997;261-271.
34. Hayes J., Scovell W.M. cis-Diamminedichloroplatinum (II) modified chromatin and nucleosomal core particle. Biochim. Biophys. Acta. 1089:1991;377-385.
35. Foka M., Paoletti J. Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution. Biochem. Pharmacol. 35:1986;3283-3291.
36. Millard J.T., Wilkes E.E. cis- and trans-Diamminedichloroplatinum(II) interstrand cross-linking of a defined sequence nucleosomal core particle. Biochemistry. 39:2000;16046-16055.
37. Luger K., Mäder A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 389:1997;251-260.
38. Richmond T.J., Finch J.T., Rushton B., Rhodes D., Klug A. Structure of the nucleosome core particle at 7 Å resolution. Nature. 311:1984;532-537.
39. Millard J.T. DNA modifying agents as tools for studying chromatin structure. Biochimie. 78:1996;803-816.
40. Houssier C., Depauw-Gillet M.C., Hacha R., Fredericq E. Alteration in the nucleosome and chromatin structures upon interaction with platinum coordination complexes. Biochim. Biophys. Acta. 739:1983;317-325.
41. Whittaker J., McFadyen W.D., Wickham G., Wakelin L.P.G., Murray V. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA. Nucleic Acids Res. 26:1998;3933-3939.
42. Temple M.D., McFadyen W.D., Holmes R.J., Denny W.A., Murray V. The interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Biochemistry. 39:2000;5593-5599.